Compounds > mannose

Page last updated: 2024-08-22

mannose and rifampin

mannose has been researched along with rifampin in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (8.33)	29.6817
2010's	8 (66.67)	24.3611
2020's	3 (25.00)	2.80

Authors

Authors	Studies
Asthana, A; Dutta, T; Jain, NK; Kumar, PV	1
Chaubey, P; Mishra, B	1
Fu, Y; Gong, T; Guo, L; Han, J; Ke, H; Lin, Q; Song, X; Sun, X; Zhang, Z	1
Chua, KL; Hsu, LY; Kang, ET; Leong, DT; Li, M; Neoh, KG; Xu, L; Yuan, L	1
Britigan, BE; Choi, SR; Moran, DM; Narayanasamy, P	1
Borges, M; Cardoso, MS; Magalhães, J; Pinheiro, M; Reis, S; Rocha, S; Santos, SG; Vieira, AC	1
Chaves, LL; Ferreira, D; Lima, SAC; Pinheiro, M; Reis, S; Sarmento, B; Vieira, ACC	1
Buttini, F; Costantino, L; Iannuccelli, V; Leo, E; Maretti, E; Rustichelli, C; Truzzi, E	1
Cai, J; Chen, C; Chen, ZW; Hu, C; Huang, D; Jin, H; Lee, BS; Pi, J; Shen, H; Shen, L; Wang, R; Wang, W; Yang, E; Zeng, G	1
Chaubey, P; Fernandes, T; Kaur, P; Narayanan, S; Prabhu, P; Sawarkar, SP; Vk, R	1
Adeyemi, SA; Choonara, YE; Kumar, P; Sumaila, M; Ubanako, P	1
Bandyopadhyaya, R; Mehra, S; Mistry, N	1

Other Studies

12 other study(ies) available for mannose and rifampin

Article	Year
Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. Journal of drug targeting, 2006, Volume: 14, Issue:8 Topics: Animals; Antibiotics, Antitubercular; Calorimetry, Differential Scanning; Chlorocebus aethiops; Dendrimers; Drug Delivery Systems; Hemolysis; Humans; Hydrogen-Ion Concentration; Macrophages, Alveolar; Magnetic Resonance Spectroscopy; Mannose; Microscopy, Electron, Scanning; Phagocytosis; Rats; Rifampin; Solubility; Spectrophotometry, Infrared	2006
Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Carbohydrate polymers, 2014, Jan-30, Volume: 101 Topics: Animals; Biological Transport; Chemical Phenomena; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Leishmaniasis, Visceral; Male; Mannose; Nanoparticles; Rats; Rifampin	2014
Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery. Pharmaceutical research, 2015, Volume: 32, Issue:5 Topics: Animals; Antibiotics, Antitubercular; Cell Line; Drug Carriers; Drug Delivery Systems; Humans; Lipids; Macrophages, Alveolar; Male; Mannose; Mice; Nanostructures; Particle Size; Rats, Wistar; Rifampin; Tissue Distribution	2015
Sugar-Grafted Cyclodextrin Nanocarrier as a "Trojan Horse" for Potentiating Antibiotic Activity. Pharmaceutical research, 2016, Volume: 33, Issue:5 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Cyclodextrins; Ciprofloxacin; Click Chemistry; Drug Carriers; Drug Resistance, Bacterial; Erythromycin; Glucose; Humans; Mannose; Microbial Sensitivity Tests; Rifampin; Staphylococcus aureus	2016
Gallium nanoparticles facilitate phagosome maturation and inhibit growth of virulent Mycobacterium tuberculosis in macrophages. PloS one, 2017, Volume: 12, Issue:5 Topics: Antitubercular Agents; Cathepsin D; Cell Survival; Cells, Cultured; Dendrimers; Folic Acid; Galectin 3; Gallium; Humans; Macrophages; Mannose; Metal Nanoparticles; Mycobacterium tuberculosis; Particle Size; Phagosomes; Polymers; Rifampin; Virulence	2017
Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment. Nanomedicine (London, England), 2017, Volume: 12, Issue:24 Topics: Animals; Antibiotics, Antitubercular; Biological Transport; Cell Survival; Drug Carriers; Drug Liberation; Female; Humans; Hydrogen-Ion Concentration; Lipids; Macrophages; Mannose; Mice, Inbred C57BL; Mycobacterium avium; Nanoparticles; Particle Size; Rifampin; Surface Properties; Tuberculosis, Pulmonary	2017
Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages. Artificial cells, nanomedicine, and biotechnology, 2018, Volume: 46, Issue:sup1 Topics: Biological Transport; Cell Survival; Drug Carriers; Drug Liberation; Humans; Hydrogen-Ion Concentration; Intracellular Space; Lipids; Macrophages; Mannose; Nanoparticles; Rifampin	2018
Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy. Drug delivery and translational research, 2019, Volume: 9, Issue:1 Topics: Animals; Antibiotics, Antitubercular; Cell Line; Drug Liberation; Dry Powder Inhalers; Female; Lectins, C-Type; Macrophages; Mannose; Mannose Receptor; Mannose-Binding Lectins; Mice; Mycobacterium tuberculosis; Nanoparticles; Receptors, Cell Surface; Rifampin; Surface Properties; Surface-Active Agents	2019
Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency. Materials science & engineering. C, Materials for biological applications, 2019, Volume: 103 Topics: Animals; Drug Delivery Systems; Graphite; Humans; Macaca mulatta; Macrophages; Mannose; Mycobacterium tuberculosis; Nanoparticles; Rifampin; THP-1 Cells; Tuberculosis	2019
Mannose-conjugated chitosan nanoparticles for delivery of Rifampicin to Osteoarticular tuberculosis. Drug delivery and translational research, 2021, Volume: 11, Issue:4 Topics: Chitosan; Drug Carriers; Humans; Mannose; Nanoparticles; Particle Size; Rifampin; Tuberculosis, Osteoarticular	2021
Dual Rifampicin and Isoniazid Mannose-Decorated Lipopolysaccharide Nanospheres for Macrophage- Targeted Lung Delivery. Current drug delivery, 2023, Volume: 20, Issue:10 Topics: Humans; Isoniazid; Lipopolysaccharides; Macrophages; Mannose; Nanoparticles; Nanospheres; Rifampin; Tuberculosis	2023
Enhancement of Antimycobacterial Activity of Rifampicin Using Mannose-Anchored Lipid Nanoparticles against Intramacrophage Mycobacteria. ACS applied bio materials, 2022, 12-19, Volume: 5, Issue:12 Topics: Antitubercular Agents; Humans; Mannose; Mycobacterium tuberculosis; Rifampin; Tuberculosis	2022